We are an IND-stage drug discovery and development platform advancing transformative new medicines. Our proprietary R2i technology delivers novel therapeutics that overcome the side effect profiles and limited efficacy of traditional pharmacological approaches by leveraging a new dimension of disease biology. Blue’s proprietary receptor-interactomics™ approach is creating deep insights to deliver superior outcomes for patients.
View Top Employees from Blue TherapeuticsWebsite | http://www.bluetherapeutics.com |
Revenue | $1 million |
Employees | 2 (1 on RocketReach) |
Founded | 2015 |
Address | 203 Crescent St Suite 110, Waltham, Massachusetts 02453, US |
Phone | (617) 475-0955 |
Technologies |
JavaScript,
HTML,
Twitter
+8 more
(view full list)
|
Industry | Biotechnology, Drug Development, Pharmaceuticals, Drug Discovery, Healthcare, Analgesics |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 541714 Companies |
Looking for a particular Blue Therapeutics employee's phone or email?
The Blue Therapeutics annual revenue was $1 million in 2023.
Stefan Bluemmers is the President and Chief Executive Officer of Blue Therapeutics.
1 people are employed at Blue Therapeutics.
Blue Therapeutics is based in Waltham, Massachusetts.
The NAICS codes for Blue Therapeutics are [54171, 54, 5417, 541, 541714].
The SIC codes for Blue Therapeutics are [873, 87].